SUB1P2

Across TCGA pan-cancer cohorts, SUB1P2 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated SUB1P2 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher SUB1P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SUB1P2 expression acts as an unfavorable survival marker, although some lineages such as LUAD and STAD show a favorable association.

LIHC, KICH, and UVM are the cancer types where SUB1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	All	0.106	0.546	<.001	114	view →
KICH	DFS	Tertile	All	0.079	0.891	<.001	84	view →
UVM	OS	Tertile	III,IV	0.037	0.809	<.001	52	view →
LUAD	DFS	Tertile	II,III,IV	0.882	0.648	.006	48	view →
OV	DFS	Quartile	III,IV	0.437	0.557	.009	42	view →
KIRC	DFS	Tertile	IV	0.186	0.623	<.001	36	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
CESC	DFS	Quartile	IV	0.321	0.580	.024	24	view →
LGG	DFS	Tertile	All	0.532	0.755	<.001	21	view →
ESCA	DFS	Quartile	All	0.338	0.569	.002	18	view →
PCPG	OS	Tertile	All	0.556	0.967	<.001	18	view →
ACC	OS	Tertile	III,IV	0.189	0.757	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

SUB1P2–LIHC (DFS)

Open the LIHC breakdown →